Crossmark

Identification of (S)-selective transaminases for the asymmetric synthesis of bulky chiral amines

Crossref DOI link: https://doi.org/10.1038/nchem.2578

Published Online: 2016-07-18

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pavlidis, Ioannis V. https://orcid.org/0000-0001-5811-368X
Weiß, Martin S.

Genz, Maika

Spurr, Paul

Hanlon, Steven P.

Wirz, Beat

Iding, Hans

Bornscheuer, Uwe T. https://orcid.org/0000-0003-0685-2696
License Information

Text and Data Mining valid from 2016-07-18
More Information

Article History

Received: 4 February 2016

Accepted: 16 June 2016

First Online: 18 July 2016

Competing interests

: The biocatalysis group of Roche has a committed interest over the long term in establishing a set of technically applicable TAs with broad substrate acceptance to assist devising more attractive, shorter, economical and greener synthetic routes to investigational drugs and beyond.